Yawen Zhang

Yawen Zhang practices at Staten Island University Hospital - North Campus in Staten Island, New York.

Yawen Zhang's NPI, 1093344137, was assigned on April 1, 2020. Yawen Zhang holds New York license 331720-01.

Yawen Zhang's primary practice is Staten Island University Hospital - North Campus, at 475 Seaview Ave, Staten Island, NY 10305 in Richmond County. The practice phone is (718) 226-4502.

Yawen Zhang's primary practice is Staten Island University Hospital - North Campus in Staten Island, New York. Yawen Zhang is also affiliated with Staten Island University Hospital. The medical group on file is Summit Oaks Hospital. Dmand AI also links Yawen Zhang to 2 more hospitals and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Yawen Zhang practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Yawen Zhang's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Yawen Zhang's licenses on file in 2 states: New York and New Jersey.

CMS data shows 1,094 Medicare services from Yawen Zhang across 6 procedure codes in 2024, for 406 Medicare patients. Medicare paid $92,487 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 406 Medicare patients who saw Yawen Zhang in 2024. The largest group is 75 to 84, with 129 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 32% are also on Medicaid. Their average risk score is 2.44, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Yawen Zhang's median patient age at 73, with 47% women.

In 2024, Yawen Zhang wrote 235 Medicare Part D claims for 106 patients. 91% of them were for generic drugs. CMS names the drug for 28 of them, across 2 drugs with 11 or more claims each, at $489 in total drug cost. In 2023, CMS named 25 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Yawen Zhang for performance year 2024, reported through an alternative payment model (APM). Yawen Zhang accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Yawen Zhang, published from 2014 to 2016. The most frequent topics are Cholesterol, 1,2-Dipalmitoylphosphatidylcholine and Lipid Bilayers. Yawen Zhang's most frequent co-authors are Analise Douglas, MD, Daniel Michael Matassa, MD and Hyo-Bin Um, MD.

CMS Open Payments shows 2 general payments to Yawen Zhang from 1 drug or device company in 2024. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $31.